Enovix (NASDAQ:ENVX) Shares Up 12.9% - Still a Buy?

Key Points

• Enovix shares jumped 12.9% to $2.54 on elevated trading volume, but the stock remains below its 50-day and 200-day moving averages.
• Analyst sentiment is mixed but leans positive: MarketBeat reports a “Moderate Buy” consensus, with an average price target of $10.77 versus the current price, though some firms have downgraded the stock or maintained sell/neutral ratings.
• Enovix exceeded quarterly expectations with an adjusted loss of $0.13 per share and $9.02 million in revenue, up 20.8% year over year; however, the company continues to report deeply negative margins and return on equity.

Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s stock price was up 12.9% on Wednesday. The company traded as high as $2.56 and last traded at $2.54. 8,603,721 shares were traded during mid-day trading, an increase of 26% from the average session volume of 6,852,621 shares. The stock had previously closed at $2.25.

Analyst Ratings Changes

Several brokerages recently issued reports on ENVX. William Blair cut Enovix from an "outperform" rating to a "market perform" rating in a research note on Monday, August 17th. Weiss Ratings reissued a "sell (e+)" rating on shares of Enovix in a research report on Friday, October 2nd. Canaccord Genuity Group reduced their price target on Enovix from $15.00 to $10.00 and set a "buy" rating on the stock in a research report on Friday, August 14th. Cantor Fitzgerald restated an "overweight" rating and set a $25.00 target price on shares of Enovix in a research note on Thursday, August 13th. Finally, Bank of America restated a "neutral" rating and issued a $5.00 target price on shares of Enovix in a report on Monday, August 17th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Enovix presently has an average rating of "Moderate Buy" and an average price target of $10.77.

Enovix Trading Up 12.9%

The stock has a market cap of $557.40 million, a price-to-earnings ratio of -3.14 and a beta of 2.49. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46. The business has a 50 day simple moving average of $3.08 and a two-hundred day simple moving average of $4.98.

Enovix (NASDAQ:ENVX - Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. The firm had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The firm's revenue for the quarter was up 20.8% on a year-over-year basis. During the same period last year, the company earned ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. As a group, equities analysts anticipate that Enovix Corporation will post -0.79 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Sax Wealth Advisors LLC acquired a new position in shares of Enovix in the 3rd quarter worth approximately $29,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Enovix in the 4th quarter valued at about $30,000. Calamos Advisors LLC bought a new stake in shares of Enovix in the 1st quarter valued at $60,000. Sequoia Financial Advisors LLC acquired a new position in shares of Enovix in the second quarter valued at approximately $61,000. Finally, Gateway Wealth Partners LLC bought a new position in shares of Enovix during the first quarter worth about $68,000. 50.92% of the stock is owned by institutional investors and hedge funds.

About Enovix

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company's design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.